Please login to the form below

Not currently logged in
Email:
Password:

PharmaFutures reports on unmet need

The global pharma industry must work with healthcare providers to ensure that vital medical research translates into affordable drugs for priority health needs, according to a report by the PharmaFutures project

The global pharma industry must work with healthcare providers to ensure that vital medical research translates into affordable drugs for priority health needs, according to a report by the PharmaFutures project.

The report, Shared Value: Rebuilding Pharma's Contract with Society, the fourth report of the PharmaFutures project, identifies a growing mismatch between unmet patient need and R&D, driven by changes in what society is willing to pay for and concerns among investors about the return on investment.

Sophia Tickell, PharmaFutures director, said: "The industry's social contract is under severe strain. There is an urgent need for new treatments for antibiotics and diseases like Alzheimer's. It is in the interest of patients, healthcare providers, industry and pension holders to work together to create the best model for bringing new drugs to market."

The initial PharmaFutures project was founded in 2003 and is coordinated by Meteos, a non-profit company that facilitates investor-led dialogues and cross-sector networks that explore long-term value creation across critical sectors.

23rd June 2011

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

Harness the power of data to map new patient pathways
Oli Hudson, of Wilmington Healthcare, explains why pharma needs to put data at the heart of its bid to support the NHS Reset...
What NORD’s RareInsights® 30-year comparative analysis means to us and our clients at OPEN Health
...
Peter Jackson
Rethinking our approach to infectious disease preparedness
The importance of long-term strategic investment to prepare for the next threat that emerges...

Infographics